Schedule an Appointment


Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.

Book a Conference Call
Get More Information


Location: Seattle, WA

Sector: Health.

Add to Shortlist
Express Interest

LEVL has created a new paradigm in nutrition management and health through a non-invasive, simple and highly accurate measurement of ketosis using breath. Having recently launched the LEVL device with positive market feedback, LEVL is seeking a strategic partner or investment to fully capitalize on the large and rapidly evolving market in telehealth care and population health management.

Our patented and proprietary Bluetooth-enabled LEVL device and app provide insights and measurements that are not available through any other means.

Obesity is common and expensive

39.8% of Americans are obese. The estimated annual medical cost of obesity in the U.S. was $147 billion in 2008 U.S. dollars; the medical cost for people who have obesity was $1,429 higher than those of normal weight.

Source: CDC


Obesity related diseases are preventable

Obesity-related conditions include heart disease, stroke, type 2 diabetes and certain types of cancer, some of the leading causes of preventable death.


Ketogenic diets in disease management

Recent scientific studies have demonstrated that a state of ketosis can aid in weight loss, improve brain function in Alzheimer’s and dementia patients, cause tumor regression, reduce epilepsy, and reverse Type 2 Diabetes.

Multiple diseases have been shown to respond to elevated levels of ketone bodies (or a state of ketosis). These diseases may be grossly defined by one of three categories:

  • Problems generating energy from carbohydrates (brain dysfunction, epilepsy)
  • Increased reactive oxygen species (ROS) (cancer, inflammation),
  • Triggered by elevated insulin and blood glucose (cancer, diabetes).


Measures ketones bodies with a simple breath. No more blood draws or messy urine strips.


Ability to share data with clinician/health coach

Aligning with the growth in telehealth, LEVL gives usersthe ability to share daily metabolic data remotely with their clinician/health coach via the LEVL mobile app and LEVLpro dashboard


FDA Registered

Class I Medical Device


Clinically accurate

Device calibration and monthly (30-day) sensor change ensure clinical accuracy


Unlimited measurements

Unlimited measurements can be taken on each 30 day sensor allowing users to learn the impacts of wellness choices throughout the day.


LEVLhome – 2 users

LEVLhome is designed for 2 user in a home setting

LEVLpro – unlimited users

LEVLpro is designed for unlimited users in a professional (health clinic, doctors office) setting


Measure low levels of ketosis

The only product designed to measure low levels of nutritional ketosis allowing users to better understand the impacts on fat metabolism and fat loss projections. Blood and urine strips are designed to measure ketoacidosis.



Provides detailed insights with tracking and historical trends.



Our shared API allows users to track multiple biomarkers (sleep, macros, steps, glucose, etc.) on larger platforms (i.e. Heads Up Health)

Brent Hixson, President and CEO

Brent joined LEVL in 2013 to lead the company from the initial research and development efforts through product development while building an exceptional cross-disciplined team and preparing for market launch.

Prior to joining LEVL, Brent was a business leader in the highly regulated markets of aerospace and medical devices which includes cross functional positions in operations, supply chain management, marketing and sales leadership. At LEVL, Brent lives out his entrepreneurial interests in a fast-paced and innovative environment.


LaMonte Lamoureux, Director of Business Development

LaMonte started his career as a sales representative for a leading medical manufacturer and brings 15 year of sales leadership in healthcare to the LEVL team. His experience includes growing distribution channels, managing sales teams and developing innovative sales strategies while evaluating changes in the healthcare industry.

At LEVL, LaMonte is responsible for implementing our go-to-market sales strategy, managing the sales team, tracking results and trends for business forecasting and analyzing sales statistics. He is excited about LEVL’s innovative technology to improve customers’ health and wellness outcomes.